Four-week therapy with the 5-HT3 receptor antagonist tropisetron in fibromyalgia

Authors
Category Primary study
JournalAktuelle Rheumatologie
Year 2000
This article has no abstract
Epistemonikos ID: 73324829135eb8995ca345e179b4c67a7a232556
First added on: Feb 03, 2025